Stay updated on Nivolumab with RT for Head & Neck Melanoma Clinical Trial
Sign up to get notified when there's something new on the Nivolumab with RT for Head & Neck Melanoma Clinical Trial page.

Latest updates to the Nivolumab with RT for Head & Neck Melanoma Clinical Trial page
- Check5 days agoChange DetectedPage revision label updated from v3.4.2 to v3.4.3 in the footer.SummaryDifference0.1%

- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedMelanoma and related topics (MedlinePlus Genetics) were removed from the page, reducing disease-specific contextual content. The change eliminates keywords and links that help users understand the study focus and locate related information.SummaryDifference0.2%

- Check27 days agoChange DetectedAdded Melanoma to the related topics section and linked MedlinePlus Genetics as a related topics reference. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check34 days agoChange DetectedAdded Revision: v3.4.2 to the page. Removed the funding-notice, Melanoma-related topics, and the previous Revision: v3.4.1 reference.SummaryDifference0.8%

- Check41 days agoChange DetectedAdded a site-wide notice about a lapse in government funding with guidance to check opm.gov for status updates, and updated the revision to v3.4.1.SummaryDifference0.5%

- Check48 days agoChange DetectedShow glossary option is now visible, and boilerplate labels were updated to 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data'; the revision tag was updated from v3.3.4 to v3.4.0.SummaryDifference0.3%

Stay in the know with updates to Nivolumab with RT for Head & Neck Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab with RT for Head & Neck Melanoma Clinical Trial page.